Efficacy of Once Daily Darunavir/Ritonavir in PI-Naïve, NNRTI-Experienced Patients in the ODIN Trial

Table 2

Efficacy results at week 48 for protease inhibitor naïve patients in the ODIN trial.

	Darunavir/ritonavir; 800/100 mg once daily	Darunavir/ritonavir; 600/100 mg twice daily
	135	137
HIV-1 RNA <50 copies/mL	111 (82%)	109 (80%)
HIV-1 RNA <400 copies/mL	118 (87%)	115 (84%)

All results shown are (%), unless otherwise stated.